The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

UPDATE 1-EU backs Poland's plan to give Ukraine extra 1.2 mln vaccine doses, says Kyiv

Wed, 10th Feb 2021 16:20

(Adds details)

KYIV, Feb 10 (Reuters) - The European Commission will
support Poland's intention to provide Ukraine with an additional
batch of 1.2 million doses of AstraZeneca vaccine, the
Ukrainian government said on Wednesday.

Commission Vice-President Valdis Dombrovskis said the EU was
ready to help Ukraine with delivery of the batch, the government
said in a statement.

One of Europe's poorest countries, Ukraine has lagged behind
others in starting its vaccination programme against COVID-19,
which has infected more than 1.25 million Ukrainians and killed
23,934 as of Feb. 10.

President Volodymyr Zelenskiy this week said Ukraine, which
hopes to vaccinate half of its population by early 2022, was in
talks with other countries including Poland about receiving some
of their vaccines.

It has called on the European Union and EU member states for
help in securing vaccines, while resisting buying Russia's
Sputnik V vaccine due to toxic relations between the two
countries since Moscow's annexation of Crimea in 2014.

Zelenskiy said last week that Ukraine had secured 20 million
doses from India's Serum Institute and the global COVAX scheme.

The health ministry also agreed in December to buy 1.9
million doses from China's Sinovac Biotech at $18 per
shot via a Ukrainian intermediary, the pharmaceutical firm
Lekhim.

Anti-corruption campaigners said the deal was expensive and
a prosecutor said on Wednesday Ukraine's anti-corruption bureau
had begun an investigation into whether the government paid too
much.
(Reporting by Natalia Zinets, writing by Pavel Polityuk;
editing by John Stonestreet and Giles Elgood)

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.